Therapeutic Use of Heme Analogs: Absorption in Intestine

血红素类似物的治疗用途:肠道吸收

基本信息

  • 批准号:
    7815755
  • 负责人:
  • 金额:
    $ 1.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2009-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neonatal jaundice occurs in 60-70% of all newborn infants. It is due to hyperbilirubinemia caused not only by an overproduction of bilirubin, but also by a transient failure to excrete this metabolite. Hyperbilirubinemia is exacerbated by hemolytic diseases, such as Rhesus isoimmunization and ABO incompatibility, which result in increased bilirubin production, as well as diseases that result in decreased bilirubin excretion. The rate- limiting enzyme in the production of bilirubin is heme oxygenase (HO), and as such is a key therapeutic target. Inhibition of HO activity has been shown to protect newborns from excessive hyperbilirubinemia. Heme analogs, metalloporphyrins (Mps), are potent competitive inhibitors of HO enzyme activity. The use of Mps as oral therapeutic agents may be an effective approach for the prevention and treatment of hyperbilirubinemia. In this competing renewal, we propose to logically extend our findings from the previous funded proposal to investigate the efficacy of the oral administration of tin mesoporphyrin (SnMP), other selected heme analogs, and non-porphyrin inhibitors of HO to the heme-loaded newborn mouse, a model analogous to the human infant with increased bilirubin production. In this evaluation, we will assess their accessibility to the brain, their short- and long-term effects, response following another heme load, and the mechanisms by which this response is mediated. In the previous funding period, we have continued to develop and validate assays to monitor both in vivo bilirubin production and HO-1 transcriptional patterns and in vitro enzymatic activity of HO so that we can evaluate regulation and expression at these levels. Application of these approaches to the newborn mouse model is a natural extension of our previous work with the adult rodent models. The results of this project will assist in the design of clinical studies for these and related compounds by providing both spatial and temporal information pertaining to direct effects on the enzymatic target, its expression, and subsequent short- and long-term effects on the newborn animal. The specific aims of this application are still directed at evaluating the efficacy and safety of the oral administration of selected Mps, a class of heme analogs, for their therapeutic value to neonatal jaundice through inhibition of HO activity. We will further expand these studies to an overall evaluation of selected Mps, which we have shown to be orally absorbed, and non-porphyrin inhibitors of HO, but with particular emphasis on the study of their accessibility to the brain and other non-target tissues as well as their short- and long-term effects in the heme-loaded newborn mouse.
描述(由申请人提供):新生儿黄疸发生在所有新生儿的60-70%。这是由于高胆红素血症引起的,不仅是由于胆红素的过量产生,而且也是由于短暂的失败排泄这种代谢物。溶血性疾病,如恒河猴等免疫和ABO不相容,导致胆红素产生增加,以及导致胆红素排泄减少的疾病,加重了高胆红素血症。胆红素生成的限速酶是血红素加氧酶(HO),因此是一个关键的治疗靶点。抑制HO活性已被证明可保护新生儿免于过度高胆红素血症。血红素类似物,金属卟啉(Mps),是HO酶活性的有效竞争性抑制剂。使用Mps作为口服治疗剂可能是预防和治疗高胆红素血症的有效途径。在这个竞争性的更新中,我们建议从逻辑上扩展我们的发现,从之前的资助提案中研究口服中卟啉锡(SnMP),其他选择的血红素类似物和HO的非卟啉抑制剂对血红素负载的新生小鼠的功效,这是一个类似于人类婴儿的模型,其胆红素产生增加。在这项评估中,我们将评估它们对大脑的可及性,它们的短期和长期影响,在另一种血红素负荷后的反应,以及这种反应的介导机制。在之前的资助期内,我们继续开发和验证检测,以监测体内胆红素生成和HO-1转录模式以及HO的体外酶活性,以便我们可以评估这些水平上的调控和表达。这些方法在新生小鼠模型中的应用是我们以前在成年啮齿动物模型中工作的自然延伸。这个项目的结果将通过提供与酶靶的直接作用、其表达以及随后对新生动物的短期和长期影响有关的空间和时间信息,帮助设计这些和相关化合物的临床研究。该应用的具体目的仍然是评估口服选定的Mps(一类血红素类似物)的有效性和安全性,因为它们通过抑制HO活性对新生儿黄疸具有治疗价值。我们将进一步扩大这些研究,对选定的Mps进行全面评估,我们已经证明Mps是口服吸收的,以及HO的非卟啉抑制剂,但特别强调研究它们对大脑和其他非靶组织的可及性,以及它们在血红素负荷新生小鼠中的短期和长期影响。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
William A Silverman lecture.
威廉·A·西尔弗曼演讲。
Effects of zinc deuteroporphyrin bis glycol on newborn mice after heme loading.
  • DOI:
    10.1203/pdr.0b013e31822e1675
  • 发表时间:
    2011-11
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    He CX;Campbell CM;Zhao H;Kalish FS;Schulz S;Vreman HJ;Wong RJ;Stevenson DK
  • 通讯作者:
    Stevenson DK
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID K STEVENSON其他文献

DAVID K STEVENSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID K STEVENSON', 18)}}的其他基金

Chromium Mesoporphyrin in the Prevention of Neonatal Jaundice
铬中卟啉预防新生儿黄疸
  • 批准号:
    7945355
  • 财政年份:
    2009
  • 资助金额:
    $ 1.4万
  • 项目类别:
Chromium Mesoporphyrin in the Prevention of Neonatal Jaundice
铬中卟啉预防新生儿黄疸
  • 批准号:
    7778390
  • 财政年份:
    2009
  • 资助金额:
    $ 1.4万
  • 项目类别:
NEUROFIBROMATOSIS SCREENING
神经纤维瘤病筛查
  • 批准号:
    7718505
  • 财政年份:
    2008
  • 资助金额:
    $ 1.4万
  • 项目类别:
Effects of Statins on Heme Oxygenase-1 Regulation
他汀类药物对血红素加氧酶 1 调节的影响
  • 批准号:
    7210136
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:
CANDIDIASIS
念珠菌病
  • 批准号:
    7605206
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:
ELBW
低体重儿
  • 批准号:
    7605154
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN ELBW INFANTS
ELBW 婴儿的表面活性剂气道正压和脉搏血氧饱和度试验
  • 批准号:
    7605226
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:
SURFACTANT POSITIVE AIRWAY PRESSURE AND PULSE OXIMETRY TRIAL IN ELBW INFANTS
ELBW 婴儿的表面活性剂气道正压和脉搏血氧饱和度试验
  • 批准号:
    7717880
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:
NEUROFIBROMATOSIS SCREENING
神经纤维瘤病筛查
  • 批准号:
    7604963
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:
Effects of Statins on Heme Oxygenase-1 Regulation
他汀类药物对血红素加氧酶 1 调节的影响
  • 批准号:
    7359601
  • 财政年份:
    2007
  • 资助金额:
    $ 1.4万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 1.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了